Stay informed with the latest updates for the inheritable blood disorders community. Industry BioMarin Announces FDA’s Extended Review of Investigational… Mar 10, 2023 Industry uniQure Announces Published Trial Results for Approved Gene Therapy Feb 27, 2023 Industry FDA Approves ALTUVIIIO™ for Hemophilia A Patients Feb 24, 2023 Industry Sanofi Announces New Efanesoctocog alfa Data Published in the NEJM Jan 30, 2023 Industry New FIX Chromogenic Assay Launched by Precision BioLogic Jan 18, 2023 Industry Biomarin Provides Hemophilia A Clinical Development Program Updates Jan 10, 2023 Industry Takeda Announces Trial Results on Investigational Therapy for… Jan 10, 2023 Industry Pfizer Announces Trial Updates for Investigational Hemophilia Gene Therapy… Jan 4, 2023 Industry Spark Announces SPK-8011 Updates at ASH Dec 15, 2022 Industry BioMarin Shares Community Update for Valoctocogene Roxaparvovec Oct 3, 2022 Industry Recruitment Reopened for Phase 3 AFFINE Gene Therapy Trial Sep 23, 2022 Industry FDA Grants Priority Review for Sanofi’s BIVV001 Sep 6, 2022 Industry Rare Factor X Deficiency Survey Shows Disparity in Care Sep 1, 2022 Industry BioMarin Presents Abstract on Vector DNA Transmission Risk at ISTH Aug 4, 2022 Industry New Prophylaxis Approval for REBINYN® Aug 3, 2022 Pagination First page Previous page Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Last page